Understanding Neonatal Jaundice in Rwanda

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Jaundice, Neonatal
Interventions
DEVICE

Brilliance

The intervention is the provision of the Brilliance phototherapy machines to hospitals. This device is to be provided to facilities regardless of the study -- the study's involvement has been to collaborate with the Ministry of Health so that Brilliance is distributed in a randomized staggered method. In that sense, the study may be considered observational, as the study is not driving whether or not a hospital receives Brilliance, only when it receives Brilliance in a short time frame.

Trial Locations (1)

Unknown

University Central Hospital of Kigali, Kigali

Sponsors
All Listed Sponsors
collaborator

Rwanda Pediatric Association

UNKNOWN

collaborator

Ministry of Health, Rwanda

OTHER_GOV

collaborator

Rwanda Bio-Medical Center

UNKNOWN

collaborator

Child Relief International

UNKNOWN

collaborator

D-Rev

UNKNOWN

lead

University of California, Merced

OTHER